Equities analysts expect that Cantel Medical Corp. (NYSE:CMD) will announce $238.60 million in sales for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Cantel Medical’s earnings. The highest sales estimate is $240.50 million and the lowest is $236.70 million. Cantel Medical reported sales of $228.85 million in the same quarter last year, which indicates a positive year-over-year growth rate of 4.3%. The company is expected to announce its next quarterly earnings results on Thursday, September 26th.
On average, analysts expect that Cantel Medical will report full-year sales of $917.30 million for the current financial year, with estimates ranging from $915.30 million to $919.30 million. For the next year, analysts anticipate that the business will post sales of $985.20 million, with estimates ranging from $977.70 million to $992.70 million. Zacks’ sales averages are an average based on a survey of analysts that follow Cantel Medical.
Cantel Medical (NYSE:CMD) last released its earnings results on Tuesday, June 4th. The company reported $0.55 EPS for the quarter, hitting analysts’ consensus estimates of $0.55. Cantel Medical had a return on equity of 15.52% and a net margin of 6.95%. The company had revenue of $228.55 million for the quarter, compared to the consensus estimate of $225.95 million.
NYSE:CMD traded up $0.04 during trading hours on Friday, reaching $88.72. 86,593 shares of the stock were exchanged, compared to its average volume of 268,634. The company has a quick ratio of 1.45, a current ratio of 2.33 and a debt-to-equity ratio of 0.34. The firm has a 50 day simple moving average of $83.71 and a 200-day simple moving average of $75.01. Cantel Medical has a 52 week low of $63.47 and a 52 week high of $99.68. The stock has a market capitalization of $3.72 billion, a P/E ratio of 35.35 and a beta of 1.11.
The company also recently announced a Semi-Annual dividend, which was paid on Wednesday, July 31st. Shareholders of record on Wednesday, July 17th were issued a dividend of $0.10 per share. The ex-dividend date was Tuesday, July 16th. Cantel Medical’s dividend payout ratio is presently 7.97%.
About Cantel Medical
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.
Further Reading: The limitations of an equal weight rating
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.